Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction
To access this article, please choose from the options below
PII: S0002-8703(10)00060-8
doi:10.1016/j.ahj.2009.12.021
© 2010 Mosby, Inc. All rights reserved.
